The United States has taken a serious note of the developments that led India to issue the first compulsory licence to local company Natco Pharma to manufacture a low-cost version of German drug

The exercise of sovereign power (like taxation) is limited only by what you can get away with. China steals the intellectual property rights of virtually every company that invests in that country,

In a move that could set the tone for future pharma patent battles, India’s intellectual property rights watchdog may decide tomorrow the fate of the country’s first compulsory licence

When inaugurating the 99th Indian Science Congress last month, Prime Minister Manmohan Singh urged a doubling of R&D spending, with greater private sector contributions. He also called for